FMO5 and type 2 diabetes mellitus: Interestingly, this study found that aliskiren significantly attenuated only a specific NADPH oxidase subunit p22phoxbutitdid not affect other subunits p47phox and p67phox and isoforms of Nox2 and Nox4 in a type 2 diabetic animal model [26].